A Flexible Framework for Incorporating Patient Preferences Into Q-Learning

07/22/2023
by   Joshua P. Zitovsky, et al.
0

In real-world healthcare problems, there are often multiple competing outcomes of interest, such as treatment efficacy and side effect severity. However, statistical methods for estimating dynamic treatment regimes (DTRs) usually assume a single outcome of interest, and the few methods that deal with composite outcomes suffer from important limitations. This includes restrictions to a single time point and two outcomes, the inability to incorporate self-reported patient preferences and limited theoretical guarantees. To this end, we propose a new method to address these limitations, which we dub Latent Utility Q-Learning (LUQ-Learning). LUQ-Learning uses a latent model approach to naturally extend Q-learning to the composite outcome setting and adopt the ideal trade-off between outcomes to each patient. Unlike previous approaches, our framework allows for an arbitrary number of time points and outcomes, incorporates stated preferences and achieves strong asymptotic performance with realistic assumptions on the data. We conduct simulation experiments based on an ongoing trial for low back pain as well as a well-known completed trial for schizophrenia. In all experiments, our method achieves highly competitive empirical performance compared to several alternative baselines.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
11/28/2017

Estimation and Optimization of Composite Outcomes

There is tremendous interest in precision medicine as a means to improve...
research
07/12/2012

Set-valued dynamic treatment regimes for competing outcomes

Dynamic treatment regimes operationalize the clinical decision process a...
research
04/20/2022

Estimating optimal individualized treatment rules with multistate processes

Multistate process data are common in studies of chronic diseases such a...
research
04/27/2021

Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm

A surrogate endpoint S in a clinical trial is an outcome that may be mea...
research
04/02/2019

Causal comparative effectiveness analysis of dynamic continuous-time treatment initiation rules with sparsely measured outcomes and death

Evidence supporting the current World Health Organization recommendation...
research
07/03/2020

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method

The existing cross-validated risk scores (CVRS) design has been proposed...
research
10/27/2019

A novel high-power test for continuous outcomes truncated by death

Patient reported outcomes including quality of life (QoL) assessments ar...

Please sign up or login with your details

Forgot password? Click here to reset